Cherny Izhack, Korolev Maria, Koehler Angela N, Hecht Michael H
Department of Chemistry, Princeton University, Princeton, NJ 08544, USA.
ACS Synth Biol. 2012 Apr 20;1(4):130-8. doi: 10.1021/sb200018e. Epub 2012 Apr 2.
The availability of large collections of de novo designed proteins presents new opportunities to harness novel macromolecules for synthetic biological functions. Many of these new functions will require binding to small molecules. Is the ability to bind small molecules a property that arises only in response to biological selection or computational design? Or alternatively, is small molecule binding a property of folded proteins that occurs readily amidst collections of unevolved sequences? These questions can be addressed by assessing the binding potential of de novo proteins that are designed to fold into stable structures, but are "naïve" in the sense that they (i) share no significant sequence similarity with natural proteins and (ii) were neither selected nor designed to bind small molecules. We chose three naïve proteins from a library of sequences designed to fold into 4-helix bundles and screened for binding to 10,000 compounds displayed on small molecule microarrays. Several binders were identified, and binding was characterized by a series of biophysical assays. Surprisingly, despite the similarity of the three de novo proteins to one another, they exhibit selective ligand binding. These findings demonstrate the potential of novel proteins for molecular recognition and have significant implications for a range of applications in synthetic biology.
大量从头设计的蛋白质的可得性为利用新型大分子实现合成生物学功能带来了新机遇。这些新功能中的许多都需要与小分子结合。与小分子结合的能力是仅在生物选择或计算设计的响应中才出现的特性吗?或者,小分子结合是折叠蛋白的一种特性,在未进化序列的集合中很容易出现?这些问题可以通过评估从头设计的蛋白质的结合潜力来解决,这些蛋白质被设计折叠成稳定结构,但在以下意义上是“原始的”:它们(i)与天然蛋白质没有显著的序列相似性,并且(ii)既未被选择也未被设计用于结合小分子。我们从一个设计折叠成4螺旋束的序列库中选择了三种原始蛋白质,并筛选它们与小分子微阵列上展示的10000种化合物的结合情况。鉴定出了几种结合物,并通过一系列生物物理测定对结合进行了表征。令人惊讶的是,尽管这三种从头设计的蛋白质彼此相似,但它们表现出选择性配体结合。这些发现证明了新型蛋白质在分子识别方面的潜力,并对合成生物学的一系列应用具有重要意义。